About the Role:

The Business Development Manager role is to source, develop and partner translation opportunity arising from Sanger science for onward development for societal benefit. The role holder will interact with scientific teams, identifying translation opportunity, driving IP strategy, supporting technology development, and building attractive licensing packages ready to partner with industry, R&D partners, or, working with venture formation colleagues, with our spin out companies.

You will be responsible for:

biopharmaceutical company dedicated to transforming the lives of patients with serious and rare diseases, you’ll be part of a community that prioritizes the human experience, celebrates curiosity, and values every person’s contributions to meaningful progress. That commitment has earned us recognition as Science magazine’s No. 1 Top Employer for five consecutive years, certification as a Great Place to Work® in the U.S., and a place on The Sunday Times Best Places to Work list in the UK.

For patients, for each other, and for the future of science, we’re in. Are you?

About Maxion

Never losing sight of our purpose

Mestag Therapeutics is a clinical-stage biotechnology company pioneering the discovery and development of antibody therapeutics targeting cancer and inflammatory disease. Our science is rooted in fibroblast immunology, leveraging cutting-edge biological and translational insights to uncover novel pathways that drive immune modulation in disease.

Mestag is backed by committed leading global investors, has world-class founders and a highly experienced leadership team.

Overview

Your key responsibilities:

The Centre for Protein Degradation (CPD), led by Professor Zoran Rankovic, is a recently established centre at the ICR dedicated to discovering and developing novel cancer treatments through targeted protein degradation.